胶质细胞源性神经营养因子治疗帕金森病的持续试验。 - Suppr

Continuing trials of GDNF in Parkinson's disease.

作者信息

Barker Roger A

出版信息

Lancet Neurol. 2006 Apr;5(4):285-6. doi: 10.1016/S1474-4422(06)70386-6.

DOI:10.1016/S1474-4422(06)70386-6

PMID:16545740

Abstract

摘要

相似文献

Continuing trials of GDNF in Parkinson's disease.

Lancet Neurol. 2006 Apr;5(4):285-6. doi: 10.1016/S1474-4422(06)70386-6.

GDNF in treatment of Parkinson's disease: response to editorial.

Lancet Neurol. 2006 Mar;5(3):200-2. doi: 10.1016/S1474-4422(06)70359-3.

GDNF in treatment of Parkinson's disease: response to editorial.

Lancet Neurol. 2006 Mar;5(3):202-3. doi: 10.1016/S1474-4422(06)70360-X.

Reply: GDNF poses troubling questions for doctors, drug maker.

Ann Neurol. 2006 Jun;59(6):989-90. doi: 10.1002/ana.20880.

Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?

Exp Neurol. 2008 Jan;209(1):82-8. doi: 10.1016/j.expneurol.2007.08.019. Epub 2007 Sep 14.

Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease.

Acta Med Okayama. 2007 Apr;61(2):51-6. doi: 10.18926/AMO/32888.

GDNF therapy for Parkinson's disease.

Expert Rev Neurother. 2008 Jul;8(7):1125-39. doi: 10.1586/14737175.8.7.1125.

Neurotrophic factor therapy for Parkinson's disease.

Prog Brain Res. 2010;184:237-64. doi: 10.1016/S0079-6123(10)84013-0.

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.

J Parkinsons Dis. 2019;9(2):301-313. doi: 10.3233/JPD-191576.

MRI volumetric and intensity analysis of the cerebellum in Parkinson's disease patients infused with glial-derived neurotrophic factor (GDNF).

Exp Neurol. 2006 Apr;198(2):450-6. doi: 10.1016/j.expneurol.2005.12.021. Epub 2006 Feb 7.

引用本文的文献

Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson's disease.

Drug Deliv Transl Res. 2023 Jun;13(6):1745-1765. doi: 10.1007/s13346-023-01289-9. Epub 2023 Feb 28.

Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease.

Mov Disord. 2019 Jul;34(7):1073-1078. doi: 10.1002/mds.27724. Epub 2019 May 30.

MANF improves the MPP/MPTP-induced Parkinson's disease via improvement of mitochondrial function and inhibition of oxidative stress.

Am J Transl Res. 2018 May 15;10(5):1284-1294. eCollection 2018.

Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Neurotox Res. 2017 Nov;32(4):661-670. doi: 10.1007/s12640-017-9783-0. Epub 2017 Jul 20.

Clinical applications involving CNS gene transfer.

Adv Genet. 2014;87:71-124. doi: 10.1016/B978-0-12-800149-3.00002-0.

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?

Front Pharmacol. 2014 Jul 10;5:139. doi: 10.3389/fphar.2014.00139. eCollection 2014.

Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Drugs Aging. 2014 Apr;31(4):239-61. doi: 10.1007/s40266-014-0160-x.

Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?

J Comp Neurol. 2014 Aug 15;522(12):2802-16. doi: 10.1002/cne.23577. Epub 2014 Apr 4.

Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.

Pharmaceuticals (Basel). 2012 Jun 4;5(6):553-90. doi: 10.3390/ph5060553.

Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.

PLoS One. 2011;6(11):e27728. doi: 10.1371/journal.pone.0027728. Epub 2011 Nov 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Continuing trials of GDNF in Parkinson's disease.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献